Current trials for frontline therapy of mantle cell lymphoma

Abstract Mantle cell lymphoma (MCL) is a rare and incurable subtype of non-Hodgkin’s lymphoma that generally affects older individuals. However, the use of high-dose therapy and autologous stem cell transplant has improved significantly the prognosis of this hematological malignancy, but at the cost...

Full description

Bibliographic Details
Main Authors: Raphael E. Steiner, Jorge Romaguera, Michael Wang
Format: Article
Language:English
Published: BMC 2018-01-01
Series:Journal of Hematology & Oncology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13045-018-0556-x

Similar Items